Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Marfan Syndrome Global Clinical Trials Review, H2

Marfan Syndrome Global Clinical Trials Review, H2


  Request for Sample Report

Executive Summary

Marfan Syndrome Global Clinical Trials Review, H2, 2015

GlobalData's clinical trial report, "Marfan Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Marfan Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Marfan Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Marfan Syndrome 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Marfan Syndrome 20

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Marfan Syndrome Therapeutics Clinical Trials 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

Merck & Co., Inc. 27

Clinical Trial Overview of Merck & Co., Inc. 27

A. Menarini Industrie Farmaceutiche Riunite Srl 28

Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 28

Clinical Trial Overview of Top Institutes / Government 29

Academic Medical Center 29

Clinical Trial Overview of Academic Medical Center 29

Ann & Robert H. Lurie Children's Hospital of Chicago 30

Clinical Trial Overview of Ann & Robert H. Lurie Children's Hospital of Chicago 30

Assistance Publique-Hopitaux de Paris 31

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 31

Bayside Health 32

Clinical Trial Overview of Bayside Health 32

Brigham and Women's Hospital 33

Clinical Trial Overview of Brigham and Women's Hospital 33

Cardiff University 34

Clinical Trial Overview of Cardiff University 34

Department of Health, South Africa 35

Clinical Trial Overview of Department of Health, South Africa 35

Department of Health, UK 36

Clinical Trial Overview of Department of Health, UK 36

Ghent University Hospital 37

Clinical Trial Overview of Ghent University Hospital 37

IRCCS Policlinico San Matteo 38

Clinical Trial Overview of IRCCS Policlinico San Matteo 38

Five Key Clinical Profiles 39

Appendix 69

Abbreviations 69

Definitions 69

Research Methodology 70

Secondary Research 70

About GlobalData 71

Contact Us 71

Disclaimer 71

Source 72

List of Figures

Marfan Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13

Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Marfan Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

GlobalData Methodology 70

List of Tables

Marfan Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7

Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13

Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Marfan Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015* 20

Marfan Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 21

Marfan Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 27

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2015* 28

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 29

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ann & Robert H. Lurie Children's Hospital of Chicago, 2015* 30

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 31

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2015* 32

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 33

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2015* 34

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 35

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 36

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 37

Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2015* 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Merck & Co., Inc.

A. Menarini Industrie Farmaceutiche Riunite Srl

Marfan Syndrome Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Marfan Syndrome, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com